Prevalence of occult hepatitis B amongst indian human immunodeficiency virus type 1 infected individuals-a pilot study

Medical Journal Armed Forces India

Volumn 68, Issue 1, 2012, Pages 16-19

  Sen, Sourav ^a   Panda, Shakti Prasad ^b   Shanmuganandan, K ^c   Gupta, R M ^d   Praharaj, A K ^e  

^a MILITARY HOSPITAL   (India)

^b Department of Microbiology ^*  (India)

^c ARMED FORCES MEDICAL COLLEGE   (India)

^d ARMY HOSPITAL RESEARCH AND REFERRAL   (India)

^e c o 56 APO   (India)

Author keywords

Human immunodeficiency virus; Occult hepatitis B

Indexed keywords

HEPATITIS B CORE ANTIBODY; HEPATITIS B SURFACE ANTIBODY; HEPATITIS B SURFACE ANTIGEN; VIRUS DNA;

ADULT; AGED; ARTICLE; CD4 LYMPHOCYTE COUNT; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DISEASE ASSOCIATION; DISEASE MARKER; DNA DETERMINATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; INDIAN; LIVER INJURY; MAJOR CLINICAL STUDY; MALE; OCCULT HEPATITIS B; PILOT STUDY; POLYMERASE CHAIN REACTION; PREVALENCE; VIRUS REACTIVATION;

EID: 84863793871     PISSN: 03771237     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0377-1237(11)60127-5     Document Type: Article

References (25)

1. Kane M. Global programme for control of hepatitis B infection. Vaccine 1995;13:S47-S49.
2. Arora DR, Sehgal R, Gupta N, Yadav A, Mishra N, Siwach SB. Prevalence of parent rally transmitted hepatitis viruses in clinically diagnosed cases of hepatitis. Ind J Med Microbiol 2005;23:44-47.
3. Koo YX, Tan DS, Tan IB, Quek R, Tao M, Lim ST. "Anti-HBc alone" in human immunodeficiency virus-positive and immuno-suppressed lymphoma patients. World J Gastroenterol 2009;15:3834-3835.
4. Ozaslan E, Purnak T. Controversies about occult hepatitis B virus infection. World J Gastroenterol 2009;15:4986-4987.
5. Allain J. Occult hepatitis B virus infection. Help B Annual [serial online] 2005 [cited 2010 Sep 11];2:14-30. Available from: http://www.hepatitisbannual.org/text.asp?2005/2/1/14/29373.
6. Pondé RA, Cardoso DD, Ferro MO. The underlying mechanisms for the 'anti-HBc alone' serological profile. Arch Virol 2010;155:149-158.
7. Candotti D, Allain J P. Transfusion-transmitted hepatitis B virus infection. J Hepatol 2009;51:798-809.
8. Mina P, Georgiadou SP, Rizos C, Dalekos GN, Rigopoulou EI. Prevalence of occult hepatitis B virus infection in haemodialysis patients from central Greece. World J Gastroenterol 2010;16:225-231.
9. Aghakhani A, Banifazl M, Kalantar E, et al. Occult hepatitis B virus infection in hemodialysis patients with isolated hepatitis B core antibody: a multicenter study. Ther Apher Dial 2010;14:349-353.
10. Di Stefano M, Volpe A, Stallone G, et al. Occult HBV infection in he-modialysis setting is marked by presence of isolated antibodies to HBcAg and HCV. J Nephrol 2009;22:381-386.
11. Konopnicki D, Mocroft A, de Wit S, et al. Hepatitis B and HIV: prevalence, AIDS progression, response to highly active antiretroviral therapy and increased mortality in the EuroSIDA cohort. AIDS 2005; 19:593-601.
12. Psevdos G, Kim JH, Suh JS, Sharp VL. Predictors of loss of hepatitis B surface antigen in HIV-infected patients. World J Gastroenterol 2010; 16:1093-1096.
13. Otegbayo JA, Taiwo BO, Akingbola TS, et al. Prevalence of hepatitis B and C seropositivity in a Nigerian cohort of HIV-infected patients. Ann Hepatol 2008;7:152-156.
14. Saravanan S, Velu V, Kumarasamy N, et al. Co infection of hepatitis B and hepatitis C virus in HIV-infected patients in south India. World J Gastroenterol 2007;13:5015-5020.
15. Nunez M, Rios P, Perez-Olmeda M, Soriano V. Lack of 'occult' hepatitis B virus infection in HIV-infected patients. AIDS 2002;16: 2099-2101.
16. Hofer M, Joller-Jemelka HI, Grob PI, Lüthy R, Opravil M. Frequent chronic hepatitis B virus infection in HIV-infected patients positive for antibody to hepatitis B core antigen only. Swiss Cohort Study. Eur J Clin Microbiol Infect Dis 1998;17:6-13.
17. Piroth L, Grappin M, Buisson M, Duong M, Portier H, Chavanet P. Hepatitis B virus seroconversion in HIV-HBV co-infected patients treated with highly active antiretroviral therapy. J Acquir Immune Defic Syndr 2000;23:356-357.
18. Shire NJ, Rouster SD, Stanford SD, et al. The prevalence and significance of occult hepatitis B virus in a prospective cohort of HIV-infected patients. J Acquir Immune Defic Syndr 2007;44: 309-314.
19. Rai RR, Mathur A, Mathur D, et al. Prevalence of occult hepatitis B & C in HIV patients infected through sexual transmission. Trop Gastroenterol 2007;28:19-23.
20. Gupta S, Singh S. Occult Hepatitis B Virus infection in ART-Naive HIV-Infected Patients seen at a Tertiary Care Centre in North India. BMC Infectious Diseases 2010 [cited 2010 September 11];10:53. Available from: http://www.biomedcentral.com/1471-2334/10/53.
21. Lahiri KK, Sahni AK, Gupta RM, Duhan SD, Kapila K, Jena J. Hepatitis B e antigen negative chronic hepatitis in Indian patients: a reality. MJAFI 2007;63:318-321.
22. World Health Organization. Interim WHO Clinical Staging of HIV/AIDS and HIV/AIDS Case Definitions for Surveillance [Internet]. 2005 [cited 2010 September 11]. Available from: www.who.int/hiv/pub/guide-lines/casedefinitions/en/index.html.
23. Gibney KB, Torresi J, Lemoh C, Biggs BA. Isolated core antibody hepatitis B in sub-Saharan African immigrants. J Med Virol 2008;80: 1565-1569.
24. Rodríguez-Torres M, Gonzalez-Garcia J, Bräu N, et al. Occult hepatitis B virus infection in the setting of hepatitis C virus (HCV) and human immunodeficiency virus (HIV) co-infection: clinically relevant or a diagnostic problem? J Med Virol 2007;79:694-700.
25. Lada O, Benhamou Y, Poynard T, Thibault V. Coexistence of Hepatitis B Surface Antigen (HBsAg) and Anti-HBs Antibodies in Chronic Hepatitis B virus Carriers: Influence of "a" Determinant Variants. J Virol 2006;80:2968-2975.